{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:01:08Z","timestamp":1793048468726,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004896","name":"Eisai Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004896","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.yebeh.2021.108391","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T20:46:14Z","timestamp":1635972374000},"page":"108391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy"],"prefix":"10.1016","volume":"125","author":[{"given":"Mariana","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedele","family":"Dono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Dainese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Renna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Izzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Pagliuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Placidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Biagio Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Liguori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yebeh.2021.108391_b0005","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s10072-018-3558-0","article-title":"Association between epilepsy and headache","volume":"39","author":"Mutlu","year":"2018","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.yebeh.2021.108391_b0010","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10072-017-2926-5","article-title":"The complex interrelations between two paroxysmal disorders: headache and epilepsy","volume":"38","author":"Cianchetti","year":"2017","journal-title":"Neurol Sci"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108391_b0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.gendis.2018.04.007","article-title":"Epilepsy and migraine\u2014are they comorbidity?","volume":"5","author":"Liao","year":"2018","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108391_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-015-0556-y","article-title":"Headache in epilepsy: prevalence and clinical features","volume":"16","author":"Mainieri","year":"2015","journal-title":"J Headache Pain"},{"issue":"1","key":"10.1016\/j.yebeh.2021.108391_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-020-1074-0","article-title":"The epidemiology of headaches among patients with epilepsy: A systematic review and meta","volume":"21","author":"Duko","year":"2020","journal-title":"J Headache Pain"},{"issue":"9","key":"10.1016\/j.yebeh.2021.108391_b0030","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1468-2982.1999.1909797.x","article-title":"Migraine-Related Seizures in an Epileptic Population","volume":"19","author":"Veliog;lu","year":"1999","journal-title":"Cephalalgia"},{"key":"10.1016\/j.yebeh.2021.108391_b0035","doi-asserted-by":"crossref","unstructured":"Marks DA, Ehrenberg BL. Migraine\u2010related seizures in adults with epilepsy, with EEG correlation. Neurology 1993;43:2476 LP \u2013 2476. https:\/\/doi.org\/10.1212\/WNL.43.12.2476.","DOI":"10.1212\/WNL.43.12.2476"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108391_b0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2015.243","article-title":"Management of psychiatric and neurological comorbidities in epilepsy","volume":"12","author":"Kanner","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.yebeh.2021.108391_b0045","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1468-2982.2005.00912.x","article-title":"The impact of migraine on epilepsy: a prospective prognosis study","volume":"25","author":"Velioglu","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1016\/j.yebeh.2021.108391_b0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2003.07.003","article-title":"Epilepsy and migraine","volume":"4","author":"Bigal","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108391_b0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yebeh.2015.10.018","article-title":"Ictal epileptic headache in adult life: Electroclinical patterns and spectrum of related syndromes","volume":"53","author":"Fanella","year":"2015","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.yebeh.2021.108391_b0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10194-011-0318-4","article-title":"Migralepsy, hemicrania epileptica, post-ictal headache and \u201cictal epileptic headache\u201d: A proposal for terminology and classification revision","volume":"12","author":"Belcastro","year":"2011","journal-title":"J Headache Pain"},{"issue":"8","key":"10.1016\/j.yebeh.2021.108391_b0065","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.seizure.2013.04.016","article-title":"Relations between epileptic seizures and headaches","volume":"22","author":"Gameleira","year":"2013","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2021.108391_b0070","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/head.12536","article-title":"Migraine and epilepsy: Review of the literature","volume":"55","author":"Nye","year":"2015","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.yebeh.2021.108391_b0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0333102416683925","article-title":"Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events?","volume":"38","author":"Romoli","year":"2018","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.yebeh.2021.108391_b0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2012.222","article-title":"Epilepsy: Perampanel - New promise for refractory epilepsy?","volume":"8","author":"L\u00f6scher","year":"2012","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"10.1016\/j.yebeh.2021.108391_b0085","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1111\/epi.14522","article-title":"Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study","volume":"59","author":"Villanueva","year":"2018","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2021.108391_b0090","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1756285616661115","article-title":"Two-year real-world experience with perampanel in patients with refractory focal epilepsy: Austrian data","volume":"9","author":"Rohracher","year":"2016","journal-title":"Ther Adv Neurol Disord"},{"issue":"9","key":"10.1016\/j.yebeh.2021.108391_b0095","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/epi.14520","article-title":"Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data","volume":"59","author":"Rohracher","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108391_b0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jns.2018.04.017","article-title":"Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre","volume":"390","author":"Morano","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2021.108391_b0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.yebeh.2018.01.001","article-title":"Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study","volume":"80","author":"Liguori","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108391_b0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s10194-018-0940-5","article-title":"Perampanel inhibits calcitonin gene-related peptide release from rat brainstem in vitro","volume":"19","author":"Tringali","year":"2018","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.yebeh.2021.108391_b0115","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pharmthera.2009.09.003","article-title":"The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs","volume":"124","author":"Villal\u00f3n","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.yebeh.2021.108391_b0120","doi-asserted-by":"crossref","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, Guilhoto L, Hirsch E, et al. ILAE Classification of the Epilepsies Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017;58:512\u201321. https:\/\/doi.org\/10.1111\/epi.13709.ILAE.","DOI":"10.1111\/epi.13709"},{"key":"10.1016\/j.yebeh.2021.108391_b9000","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia 2018; 38 (3rd edition):1\u2013211.","DOI":"10.1177\/0333102417738202"},{"issue":"5","key":"10.1016\/j.yebeh.2021.108391_b0125","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/cns.13098","article-title":"Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid","volume":"25","author":"Liguori","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.yebeh.2021.108391_b0130","doi-asserted-by":"crossref","first-page":"106592","DOI":"10.1016\/j.yebeh.2019.106592","article-title":"Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: a 12-month follow-up study","volume":"101","author":"Liguori","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108391_b0135","doi-asserted-by":"crossref","unstructured":"Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn) 2015;21:973\u201389. https:\/\/doi.org\/10.1212\/CON.0000000000000199.","DOI":"10.1212\/CON.0000000000000199"},{"key":"10.1016\/j.yebeh.2021.108391_b0140","doi-asserted-by":"crossref","unstructured":"American T, Society H, Statement P, New I, Treatments M, Clinical I. The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice. Headache 2019;59:1\u201318. https:\/\/doi.org\/10.1111\/head.13456.","DOI":"10.1111\/head.13456"},{"key":"10.1016\/j.yebeh.2021.108391_b0145","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Identifier NCT00154063, Efficacy and Safety Study of E2007 in Migraine Prophylaxis 2015. https:\/\/www.clinicaltrials.gov\/ct2\/show\/results\/NCT00154063?view=results (accessed April 14, 2021)."},{"key":"10.1016\/j.yebeh.2021.108391_b0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.yebeh.2016.08.004","article-title":"Sleep quality and daytime sleepiness in patients treated with adjunctive perampanel for focal seizures","volume":"63","author":"Toledo","year":"2016","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021006521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021006521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:43:22Z","timestamp":1761504202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021006521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":31,"alternative-id":["S1525505021006521"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108391","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108391","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108391"}}